Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 19 88522 03724 56418 135--
Entreprise Value (EV)2 26 02035 82438 30131 53031 05530 790
P/E ratio 8,84x17,3x17,4x14,1x12,0x10,7x
Yield 2,05%1,75%1,94%2,26%2,46%2,64%
Capitalization / Revenue 1,06x1,17x1,13x0,86x0,82x0,78x
EV / Revenue 1,39x1,90x1,76x1,50x1,40x1,32x
EV / EBITDA 6,15x8,59x7,70x7,55x6,81x6,19x
Price to Book 1,50x1,73x1,80x1,24x1,15x1,10x
Nbr of stocks (in thousands) 306 845298 249292 869292 979--
Reference price (USD) 64,873,983,961,961,961,9
Announcement Date 02/20/201902/20/202002/23/2021---
1 EUR in Million
2 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 18 75018 86121 71621 08922 16223 287
EBITDA1 4 2344 1694 9734 1754 5604 974
Operating profit (EBIT)1 3 4422 4502 8022 4022 7243 056
Operating Margin 18,4%13,0%12,9%11,4%12,3%13,1%
Pre-Tax Profit (EBT)1 3 1011 9872 3552 1052 4212 665
Net income1 2 2461 2951 4161 2711 4651 636
Net margin 12,0%6,87%6,52%6,03%6,61%7,03%
EPS2 7,334,274,824,405,155,77
Dividend per Share2 1,331,301,631,401,521,64
Announcement Date 02/20/201902/20/202002/23/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 S1 2021 Q3 2021 Q4 2022 Q1
Net sales1 5 0535 12510 1195 3385 4835 055
EBITDA1 1 035962-1 0861 0811 016
Operating profit (EBIT)1 5695031 066600629533
Operating Margin 11,3%9,82%10,5%11,2%11,5%10,6%
Pre-Tax Profit (EBT) 478421----
Net income1 299259555340322-
Net margin 5,91%5,06%5,48%6,37%5,87%-
EPS2 1,020,891,901,201,09-
Dividend per Share ------
Announcement Date 05/06/202107/30/202107/30/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 6 13513 78713 73813 39512 92012 655
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,45x3,31x2,76x3,21x2,83x2,54x
Free Cash Flow1 1 1421 5563 8871 5651 9142 187
ROE (Net Profit / Equities) 18,4%11,5%11,7%9,03%10,2%10,8%
Shareholders' equity1 12 22611 21812 07114 07414 32315 166
ROA (Net Profit / Asset) 7,89%4,06%3,60%3,27%3,66%4,09%
Assets1 28 48031 93339 28538 85940 00540 041
Book Value Per Share2 43,142,646,650,053,956,2
Cash Flow per Share2 7,649,1517,58,2710,111,5
Capex1 1 2011 2141 2601 2101 2951 374
Capex / Sales 6,40%6,44%5,80%5,74%5,84%5,90%
Announcement Date 02/20/201902/20/202002/23/2021---
1 USD in Million
2 USD
Key data
Capitalization (EUR) 18 135 430 059
Capitalization (USD) 21 060 771 175
Net sales (USD) 21 715 786 720
Number of employees 123 538
Sales / Employee (USD) 175 782
Free-Float 67,8%
Free-Float capitalization (EUR) 12 293 578 022
Free-Float capitalization (USD) 14 276 597 401
Avg. Exchange 20 sessions (USD) 26 580 139
Average Daily Capital Traded 0,15%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA